Having trouble accessing articles? Reset your cache.

Augment Bone Graft: Final Phase III data

Final data from the modified intent-to-treat (mITT) population (n=397) of a U.S. and Canadian Phase III trial showed that Augment Bone Graft was non-inferior to autograft on 15 of 16 radiographic,

Read the full 319 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE